These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 19635227

  • 21. Management of adrenocortical carcinoma: a consensus statement of the Italian Society of Endocrinology (SIE).
    Stigliano A, Chiodini I, Giordano R, Faggiano A, Canu L, Della Casa S, Loli P, Luconi M, Mantero F, Terzolo M.
    J Endocrinol Invest; 2016 Jan; 39(1):103-21. PubMed ID: 26165270
    [No Abstract] [Full Text] [Related]

  • 22. Adjuvant mitotane in adrenocortical carcinoma.
    Lee JE.
    N Engl J Med; 2007 Sep 20; 357(12):1258; author reply 1259. PubMed ID: 17891836
    [No Abstract] [Full Text] [Related]

  • 23. Rare adrenal tumors in children.
    Mihai R.
    Semin Pediatr Surg; 2014 Apr 20; 23(2):71-5. PubMed ID: 24931351
    [Abstract] [Full Text] [Related]

  • 24. [Adrenocortical carcinoma and its treatment].
    Tupikowski W, Bednarek-Tupikowska G, Florczak A.
    Postepy Hig Med Dosw (Online); 2004 Feb 26; 58():27-36. PubMed ID: 15069374
    [Abstract] [Full Text] [Related]

  • 25. Adrenocortical cancer (ACC) - literature overview and own experience.
    Dworakowska D, Drabarek A, Wenzel I, Babińska A, Świątkowska-Stodulska R, Sworczak K.
    Endokrynol Pol; 2014 Feb 26; 65(6):492-502. PubMed ID: 25554619
    [Abstract] [Full Text] [Related]

  • 26. Clinical management of adrenocortical carcinoma.
    Fassnacht M, Allolio B.
    Best Pract Res Clin Endocrinol Metab; 2009 Apr 26; 23(2):273-89. PubMed ID: 19500769
    [Abstract] [Full Text] [Related]

  • 27. Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer.
    Berruti A, Fassnacht M, Haak H, Else T, Baudin E, Sperone P, Kroiss M, Kerkhofs T, Williams AR, Ardito A, Leboulleux S, Volante M, Deutschbein T, Feelders R, Ronchi C, Grisanti S, Gelderblom H, Porpiglia F, Papotti M, Hammer GD, Allolio B, Terzolo M.
    Eur Urol; 2014 Apr 26; 65(4):832-8. PubMed ID: 24268504
    [Abstract] [Full Text] [Related]

  • 28. Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma.
    Else T, Williams AR, Sabolch A, Jolly S, Miller BS, Hammer GD.
    J Clin Endocrinol Metab; 2014 Feb 26; 99(2):455-61. PubMed ID: 24302750
    [Abstract] [Full Text] [Related]

  • 29. Neonatal Cushing Syndrome: A Rare but Potentially Devastating Disease.
    Tatsi C, Stratakis CA.
    Clin Perinatol; 2018 Mar 26; 45(1):103-118. PubMed ID: 29406000
    [Abstract] [Full Text] [Related]

  • 30. Developing treatment for adrenocortical carcinoma.
    Kerkhofs TM, Ettaieb MH, Hermsen IG, Haak HR.
    Endocr Relat Cancer; 2015 Dec 26; 22(6):R325-38. PubMed ID: 26259571
    [Abstract] [Full Text] [Related]

  • 31. New Findings on Presentation and Outcome of Patients With Adrenocortical Cancer: Results From a National Cohort Study.
    Puglisi S, Calabrese A, Ferraù F, Violi MA, Laganà M, Grisanti S, Ceccato F, Scaroni C, Di Dalmazi G, Stigliano A, Altieri B, Canu L, Loli P, Pivonello R, Arvat E, Morelli V, Perotti P, Basile V, Berchialla P, Urru S, Fiori C, Porpiglia F, Berruti A, Pia A, Reimondo G, Cannavò S, Terzolo M.
    J Clin Endocrinol Metab; 2023 Sep 18; 108(10):2517-2525. PubMed ID: 37022947
    [Abstract] [Full Text] [Related]

  • 32. Treatment of Adrenocortical Carcinoma.
    Vaidya A, Nehs M, Kilbridge K.
    Surg Pathol Clin; 2019 Dec 18; 12(4):997-1006. PubMed ID: 31672303
    [Abstract] [Full Text] [Related]

  • 33. Adrenocortical carcinoma.
    Else T, Kim AC, Sabolch A, Raymond VM, Kandathil A, Caoili EM, Jolly S, Miller BS, Giordano TJ, Hammer GD.
    Endocr Rev; 2014 Apr 18; 35(2):282-326. PubMed ID: 24423978
    [Abstract] [Full Text] [Related]

  • 34. Clinical presentation, treatment modalities and outcome in patients with adrenocortical carcinoma: A single center experience.
    Bronswijk MJH, Laenen A, Bechter OE.
    Neoplasma; 2020 Jan 18; 67(1):209-213. PubMed ID: 31777255
    [Abstract] [Full Text] [Related]

  • 35. Diagnosis and management of adrenal cortical carcinoma.
    Fulmer BR.
    Curr Urol Rep; 2007 Jan 18; 8(1):77-82. PubMed ID: 17239320
    [Abstract] [Full Text] [Related]

  • 36. Adrenocortical cancer treatment.
    Patalano A, Brancato V, Mantero F.
    Horm Res; 2009 Jan 18; 71 Suppl 1():99-104. PubMed ID: 19153517
    [Abstract] [Full Text] [Related]

  • 37. Surgical aspects in the treatment of adrenocortical carcinomas in children: data of the GPOH-MET 97 trial.
    Hubertus J, Boxberger N, Redlich A, von Schweinitz D, Vorwerk P.
    Klin Padiatr; 2012 Apr 18; 224(3):143-7. PubMed ID: 22504769
    [Abstract] [Full Text] [Related]

  • 38. Adrenocortical Cancer Treatment.
    Long SE, Miller BS.
    Surg Clin North Am; 2019 Aug 18; 99(4):759-771. PubMed ID: 31255205
    [Abstract] [Full Text] [Related]

  • 39. Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Fassnacht M, Assie G, Baudin E, Eisenhofer G, de la Fouchardiere C, Haak HR, de Krijger R, Porpiglia F, Terzolo M, Berruti A, ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org.
    Ann Oncol; 2020 Nov 18; 31(11):1476-1490. PubMed ID: 32861807
    [No Abstract] [Full Text] [Related]

  • 40. Mitotane treatment for adrenocortical carcinoma: an overview.
    De Francia S, Ardito A, Daffara F, Zaggia B, Germano A, Berruti A, Di Carlo F.
    Minerva Endocrinol; 2012 Mar 18; 37(1):9-23. PubMed ID: 22382612
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.